These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
912 related articles for article (PubMed ID: 7861484)
1. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia. Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484 [TBL] [Abstract][Full Text] [Related]
2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
4. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn P Trans R Soc Trop Med Hyg; 1995; 89(1):78-82. PubMed ID: 7747316 [TBL] [Abstract][Full Text] [Related]
5. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral centre. Hongthiamthong P; Riantawan P; Subhannachart P; Fuangtong P J Med Assoc Thai; 1994 Oct; 77(10):520-5. PubMed ID: 7745373 [TBL] [Abstract][Full Text] [Related]
6. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusion who have completed treatment. Banda H; Kang'ombe C; Harries AD; Nyangulu DS; Whitty CJ; Wirima JJ; Salaniponi FM; Maher D; Nunn P Int J Tuberc Lung Dis; 2000 Oct; 4(10):968-74. PubMed ID: 11055765 [TBL] [Abstract][Full Text] [Related]
7. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007. Kwange SO; Budambula NL Indian J Med Microbiol; 2010; 28(1):21-5. PubMed ID: 20061758 [TBL] [Abstract][Full Text] [Related]
9. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon. Kuaban C; Bercion R; Koulla-Shiro S East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410 [TBL] [Abstract][Full Text] [Related]
10. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226 [TBL] [Abstract][Full Text] [Related]
11. Three-year follow-up of patients with pulmonary tuberculosis in Guinea-Bissau, West Africa. Winqvist N; Nauclér A; Gomes V; Djamanca I; Koivula T; Jensen H; Dias F; Biberfeld G; Källenius G; Norberg R Int J Tuberc Lung Dis; 2000 Sep; 4(9):845-52. PubMed ID: 10985653 [TBL] [Abstract][Full Text] [Related]
13. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection. El-Sony AI; Khamis AH; Enarson DA; Baraka O; Mustafa SA; Bjune G Int J Tuberc Lung Dis; 2002 Dec; 6(12):1058-66. PubMed ID: 12546113 [TBL] [Abstract][Full Text] [Related]
14. The new tuberculosis. De Cock K Afr Health; 1994 Mar; 16(3):8-10. PubMed ID: 12318774 [TBL] [Abstract][Full Text] [Related]
15. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains]. Han JP; Sun SL; Li RZ; Zhang FS; Wang SC; Cheng J; Deng YF; Wang Y; Yu CB Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654 [TBL] [Abstract][Full Text] [Related]
16. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania. Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179 [TBL] [Abstract][Full Text] [Related]
17. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi. Glynn JR; Warndorff DK; Fine PE; Munthali MM; Sichone W; Pönnighaus JM Bull World Health Organ; 1998; 76(3):295-305. PubMed ID: 9744250 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults. Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099 [TBL] [Abstract][Full Text] [Related]
19. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. Elliott AM; Halwiindi B; Hayes RJ; Luo N; Tembo G; Machiels L; Bem C; Steenbergen G; Pobee JO; Nunn PP J Trop Med Hyg; 1993 Feb; 96(1):1-11. PubMed ID: 8429569 [TBL] [Abstract][Full Text] [Related]
20. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival. Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]